References
- Agrawal, M.,. 2011. Ischemic insult induced apoptotic changes in PC12 cells: Protection by trans resveratrol. European Journal of Pharmacology 666(1):5–11.
- Agrawal, M.,. 2012. Trans-Resveratrol protects ischemic PC12 cells by inhibiting the hypoxia associated transcription factors and increasing the levels of antioxidant defense enzymes. ACS Chemical Neuroscience 4(2):285–294.
- Brents, L. K.,. 2012. Natural prenylated resveratrol analogs arachidin-1 and-3 demonstrate improved glucuronidation profiles and have affinity for cannabinoid receptors. Xenobiotica 42(2):139–156.
- Chan, P. H. 2001. Reactive oxygen radicals in signaling and damage in the ischemic brain. Journal of Cerebral Blood Flow & Metabolism 21(1):2–14.
- Domoki, F.,. 2009. Rosuvastatin induces delayed preconditioning against oxygen-glucose deprivation in cultured cortical neurons. American Journal of Physiology Cell Physiology 296(1):C97–105.
- Dong, J. W.,. 2003. Intermittent hypoxia attenuates ischemia/reperfusion induced apoptosis in cardiac myocytes via regulating Bcl-2/Bax expression. Cell Research 13(5):385–391.
- Giovannelli, L.,. 2011. Protective effects of resveratrol against senescence-associated changes in cultured human fibroblasts. The Journals of Gerontology Series A, Biological Sciences and Medical Sciences 66(1):9–18.
- Greer, A. K.,. 2014. Novel resveratrol-based substrates for human hepatic, renal and intestinal UDP-Glucuronosyltransferases. Chemical Research in Toxicology 27(4):536–545.
- Gutterman, D. D. 2005. Mitochondria and reactive oxygen species: An evolution in function. Circulation Research 97(4):302–304.
- Leonard, S. S.,. 2003. Resveratrol scavenges reactive oxygen species and effects radical-induced cellular responses. Biochemical and Biophysical Research Communications 309(4):1017–1026.
- Leonardo, C. C.,. 2013. Oral administration of the flavanol (−)-epicatechin bolsters endogenous protection against focal ischemia through the Nrf2 cytoprotective pathway. European Journal of Neuroscience 38(11):3659–3668.
- Pandey, K. B., and S. I. Rizvi. 2010. Protective effect of resveratrol on markers of oxidative stress in human erythrocytes subjected to in vitro oxidative insult. Phytotherapy Research 24(S1):S11–S14.
- Riley, P. A. 1994. Free radicals in biology: oxidative stress and the effects of ionizing radiation. International Journal of Radiation Biology 65(1):27–33.
- Robb, E. L., and J. A. Stuart. 2010. Trans-Resveratrol as a neuroprotectant. Molecules 15(3):1196–1212.
- Sabolovic, N., A.-C. Humbert, A. R. Pandya, and J. Magdalou. 2006. Resveratrol is efficiently glucuronidated by UDP-glucuronosyltransferases in the human gastrointestinal tract and in Caco-2 cells. Biopharmaceutics & Drug Disposition 27(4):181–189.
- Sakata, Y.,. 2010. Resveratrol protects against experimental stroke: putative neuroprotective role of heme oxygenase 1. Experimental Neurology 224(1):325–329.
- Singh, N., M. Agrawal, and S. Doré. 2013. Neuroprotective properties and mechanisms of resveratrol in in vitro and in vivo experimental cerebral stroke models. ACS Chemical Neuroscience 4(8):1151–1162.
- Sun, A. Y., Q. Wang, A. Simonyi, and G. Y. Sun. 2010. Resveratrol as a therapeutic agent for neurodegenerative diseases. Molecular Neurobiology 41(2–3):375–383.
- Zadák, Z.,. 2009. Antioxidants and vitamins in clinical conditions. Physiol Res 58(Suppl 1):S13–17.